Inventor
David J. Augeri
Inventor
Princeton, NJ, US
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds17%
C07BGeneral methods of organic chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,875,861Therapeutic compounds202010,828,288Hydrazone derivatives for the treatment of cancer202010,729,671Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancer202010,604,480(Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancer202010,604,481(Thio, oxo and seleno) semicarbazone complexes with zinc and their use for treating cancer202010,525,021Mitochondrial uncouplers for treatment of metabolic diseases and cancer202010,227,315Mitochondrial uncouplers for treatment of metabolic diseases and cancer201910,221,133(Thio, oxo, and seleno) semicarbazone complexes with zinc and their use for treating cancer20198,440,652'MST1 kinase inhibitors and methods of their use'2013RE044186'Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method'20138,404,732'Methods of treating ulcerative colitis'20138,278,462'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20128,153,804'Aryl pyridines and methods of their use'20128,093,245'4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use'20128,093,267'Methods of treating rheumatoid arthritis'20128,093,246'O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer'20127,989,656'Biaryl carboxylic acid apoptosis promoters'20117,825,142'Heterocyclic compounds, compositions comprising them and methods of their use'20107,772,267'Bicyclic modulators of androgen receptor function'20107,754,886'N-acylsulfonamide apoptosis promoters'20107,750,004'Apoptosis promoters'20107,705,033'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20107,649,098'Imidazole-based compounds, compositions comprising them and methods of their use'20107,632,858'Open chain prolyl urea-related modulators of androgen receptor function'20097,598,280'Heterocyclic compounds, compositions comprising them and methods of their use'20097,504,512'N-acylsulfonamide apoptosis promoters'20097,420,079'Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof'20087,405,234'Bicyclic modulators of androgen receptor function'20087,388,027'Bicyclic compounds as modulators of androgen receptor function and method'20086,992,102'Bicyclic modulators of androgen receptor function'20066,897,337'Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor'20056,720,338'N-acylsulfonamide apoptosis promoters'20046,693,123'Inhibitors of protein isoprenyl transferases'20046,670,386'Bicyclic modulators of androgen receptor function'20036,395,767'Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method'20026,310,095'Inhibitors of protein isoprenyl transferases'20016,288,261'Inhibitors of matrix metalloproteinases'20016,204,293'Inhibitors of protein isoprenyl transferases'20015,831,115'Inhibitors of squalene synthase and protein farnesyltransferase'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2011Patents assigned to ABBOTT LAB (8)· patent assignee history
1998–2004Based in Kenosha, WI, US· patent location history
2001–2020Based in Princeton, NJ, US· patent location history
2002–2013Patents assigned to BRISTOL MYERS SQUIBB CO (11)· patent assignee history
2005–2010Based in Emerson, NJ, US· patent location history
2009–2013Patents assigned to LEXICON PHARMACEUTICALS INC (9)· patent assignee history
2012–2013Patents assigned to AUGERI DAVID J (7)· patent assignee history
2019–2020Patents assigned to UNIV RUTGERS (8)· patent assignee history
2019–2020Based in New Brunswick, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 11 | 2002–2013 |
| LEXICON PHARMACEUTICALS INC | 9 | 2009–2013 |
| ABBOTT LAB | 8 | 1998–2011 |
| UNIV RUTGERS | 8 | 2019–2020 |
| AUGERI DAVID Jself | 7 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton, New Jersey, US | 27 | 2001–2020 |
| New Brunswick, New Jersey, US | 6 | 2019–2020 |
| Kenosha, WI, US | 4 | 1998–2004 |
| Emerson, New Jersey, US | 2 | 2005–2010 |